Nothing Special   »   [go: up one dir, main page]

HK1106444A1 - New association of a sinus node if current inhibitor and an angiotensin- converting enzyme inhibitor, and pharmaceutical compositions containing it - Google Patents

New association of a sinus node if current inhibitor and an angiotensin- converting enzyme inhibitor, and pharmaceutical compositions containing it

Info

Publication number
HK1106444A1
HK1106444A1 HK07112004.2A HK07112004A HK1106444A1 HK 1106444 A1 HK1106444 A1 HK 1106444A1 HK 07112004 A HK07112004 A HK 07112004A HK 1106444 A1 HK1106444 A1 HK 1106444A1
Authority
HK
Hong Kong
Prior art keywords
inhibitor
angiotensin
pharmaceutical compositions
compositions containing
converting enzyme
Prior art date
Application number
HK07112004.2A
Other languages
English (en)
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36685870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1106444(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1106444A1 publication Critical patent/HK1106444A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
HK07112004.2A 2005-12-21 2007-11-05 New association of a sinus node if current inhibitor and an angiotensin- converting enzyme inhibitor, and pharmaceutical compositions containing it HK1106444A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513006A FR2894825B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
HK1106444A1 true HK1106444A1 (en) 2008-03-14

Family

ID=36685870

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07112004.2A HK1106444A1 (en) 2005-12-21 2007-11-05 New association of a sinus node if current inhibitor and an angiotensin- converting enzyme inhibitor, and pharmaceutical compositions containing it

Country Status (42)

Country Link
US (2) US20070142355A1 (xx)
EP (2) EP1800678B1 (xx)
JP (2) JP4705564B2 (xx)
KR (2) KR100907583B1 (xx)
CN (1) CN101015557B (xx)
AP (1) AP2119A (xx)
AR (1) AR058574A1 (xx)
AT (1) ATE508742T1 (xx)
AU (1) AU2006252210B2 (xx)
BR (1) BRPI0605517A (xx)
CA (1) CA2571644C (xx)
CO (1) CO5790168A1 (xx)
CR (1) CR8820A (xx)
CY (1) CY1111575T1 (xx)
DK (1) DK1800678T3 (xx)
EA (1) EA011253B1 (xx)
ES (1) ES2366570T3 (xx)
FR (1) FR2894825B1 (xx)
GE (1) GEP20094604B (xx)
GT (1) GT200600522A (xx)
HK (1) HK1106444A1 (xx)
HR (1) HRP20110532T1 (xx)
IL (1) IL180204A (xx)
JO (1) JO2699B1 (xx)
MA (1) MA28723B1 (xx)
ME (1) ME01958B (xx)
MX (1) MXPA06014885A (xx)
MY (1) MY146956A (xx)
NO (1) NO337640B1 (xx)
NZ (1) NZ552221A (xx)
PE (2) PE20110116A1 (xx)
PL (1) PL1800678T3 (xx)
PT (1) PT1800678E (xx)
RS (1) RS51731B (xx)
SA (1) SA06270480B1 (xx)
SG (2) SG173243A1 (xx)
SI (1) SI1800678T1 (xx)
TW (1) TWI369206B (xx)
UA (1) UA86417C2 (xx)
UY (1) UY30023A1 (xx)
WO (1) WO2007077327A1 (xx)
ZA (1) ZA200610824B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013116738A1 (en) * 2012-02-03 2013-08-08 Cardeus Pharmaceuticals, Inc. Drug formulations
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
CA2450027A1 (en) * 2001-06-08 2002-12-19 Ortho-Mcneil Pharmaceutical, Inc. Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
US20040242565A1 (en) * 2001-09-11 2004-12-02 Yoshinori Toshima Medicinal composition for prevention of or treatment for cerebrovascular disorder and cardiopathy
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
PT1362590E (pt) * 2002-07-25 2004-05-31 Boehringer Ingelheim Pharma Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
MY146956A (en) 2012-10-15
KR100907583B1 (ko) 2009-07-14
GT200600522A (es) 2007-07-25
AU2006252210A1 (en) 2007-07-05
PL1800678T3 (pl) 2011-08-31
NO337640B1 (no) 2016-05-23
SG133545A1 (en) 2007-07-30
EP1800678A1 (fr) 2007-06-27
AP2006003859A0 (en) 2006-12-31
EP2298297A1 (fr) 2011-03-23
TW200744608A (en) 2007-12-16
ES2366570T3 (es) 2011-10-21
EA011253B1 (ru) 2009-02-27
CY1111575T1 (el) 2015-10-07
JP2011079854A (ja) 2011-04-21
DK1800678T3 (da) 2011-08-15
BRPI0605517A (pt) 2007-10-16
UY30023A1 (es) 2007-01-31
NZ552221A (en) 2008-05-30
AU2006252210B2 (en) 2012-04-26
PE20110116A1 (es) 2011-03-02
JP2007169283A (ja) 2007-07-05
UA86417C2 (ru) 2009-04-27
IL180204A0 (en) 2008-01-20
ATE508742T1 (de) 2011-05-15
ME01958B (me) 2011-10-31
CA2571644A1 (fr) 2007-06-21
WO2007077327A1 (fr) 2007-07-12
PE20071004A1 (es) 2007-11-17
AP2119A (en) 2010-04-21
CN101015557A (zh) 2007-08-15
CO5790168A1 (es) 2007-08-31
CR8820A (es) 2007-08-28
EP1800678B1 (fr) 2011-05-11
PT1800678E (pt) 2011-07-12
JP4705564B2 (ja) 2011-06-22
KR20070066921A (ko) 2007-06-27
JO2699B1 (en) 2013-03-03
CA2571644C (fr) 2011-03-08
US20120196850A1 (en) 2012-08-02
US20070142355A1 (en) 2007-06-21
SG173243A1 (en) 2011-08-29
RS51731B (en) 2011-10-31
ZA200610824B (en) 2008-06-25
AR058574A1 (es) 2008-02-13
FR2894825B1 (fr) 2010-12-03
MXPA06014885A (es) 2009-02-11
TWI369206B (en) 2012-08-01
CN101015557B (zh) 2010-12-08
GEP20094604B (en) 2009-02-10
KR20090047424A (ko) 2009-05-12
MA28723B1 (fr) 2007-07-02
IL180204A (en) 2014-02-27
SI1800678T1 (sl) 2011-08-31
EA200602155A1 (ru) 2007-08-31
SA06270480B1 (ar) 2011-02-23
NO20065905L (no) 2007-06-22
HRP20110532T1 (hr) 2011-08-31
FR2894825A1 (fr) 2007-06-22

Similar Documents

Publication Publication Date Title
IL213342A0 (en) Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
IL236013A0 (en) Adamantyl acetamide derivatives as 11-beta-hydroxysteroid dehydrogenase type 1 enzyme inhibitors
HK1106444A1 (en) New association of a sinus node if current inhibitor and an angiotensin- converting enzyme inhibitor, and pharmaceutical compositions containing it
IL227318A (en) Preparations containing enzyme for lowering immunological pressure
HK1106442A1 (en) Association of a sinus node if, current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
WO2009066035A3 (fr) Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
GB0513316D0 (en) Scoping of IPV4 addresses
AP2008004400A0 (en) Inhibitors of HIV integrase enzyme
GB0526169D0 (en) Enzyme inhibitors
GB0417408D0 (en) Enzyme inhibitors
GB0410302D0 (en) Enzyme inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221220